具有MAPT p.K298_H299insQ突变的FTDP-17的临床和病理特征
Hiroyuki Morino1,2,3, Takashi Kurashige4, Yukiko Matsuda2
1Department of Medical Genetics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Movement disorders clinical practice
|April 12, 2024
概括
一个MAPT基因突变会导致带有帕金森症的前性痴呆症 (FTDP-17),导致非典型的帕金森症和渐进的超核性麻. 这项研究证实了insACA突变.
科学领域:
- 神经遗传学 神经遗传学
- 分子生物学分子生物学
- 神经病理学神经病理学
背景情况:
- 该MAPT基因与17号染色体 (FTDP-17) 相关的帕金森症前性痴呆症有关.
- FTDP-17是一种遗传性神经退行性疾病,具有不同的临床表现,包括帕金森症和痴呆症.
- 临床表型可以模仿帕金森病,渐进性上核性麻和皮质核综合征.
研究的目的:
- 在基因,生化和病理方面调查患有MAPT相关疾病的家庭.
- 描述一种新的MAPT突变对蛋白功能和神经病理学的影响.
- 为了将基因型与受影响个体中观察到的各种临床表型相关联.
主要方法:
- 遗传分析:链接分析,同性哈普洛类型,外体序列.
- 生物化学试验:陶蛋白微管聚合,肝素诱导的陶聚合,西部涂抹.
- 病理学检查:使用抗tau抗体和PM-PBB3在尸检脑组织上的免疫组织化学.
主要成果:
- 在受影响的个体中确定了一种新的MAPT基因变异 (c.896_897insACA,p.K298_H299insQ).
- 突变的蛋白显示微管聚合率降低,并形成异常聚合物.
- 病理学揭示了前和中脑缩,黑色质体脱色,以及FTDP-17.7.特征的阳性包容.
结论:
- 证实了insACA MAPT突变是FTDP-17.的原因.
- 观察到从帕金森症的临床进展到渐进的超核性麻症状.
- 需要对MAPT突变进行进一步的研究,以阐明常见和特定的致病机制.
相关概念视频
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...